| Logo Mark Reven Pharmaceuticals, Inc.
86628038 13 May 2015 | on 26 Feb 2019
| Pharmaceutical research and development in the fields of cardiovascula... Class 042 Class 042 Computer & Software Services & Scientific Services Pharmaceutical research and development in the fields of cardiovascular disease, vascular therapy, skin conditions, diabetic conditions, cancer, infectious disease, sports enhancement, nerve system disease, brain disease and mitochondrial disease; Pharmaceutical services, namely, the development of pharmaceuticals for the treatment of cardiovascular disease, vascular therapy, skin conditions, diabetic conditions, cancer, infectious disease, sports enhancement, nerve system disease, brain disease and mitochondrial disease | | | REVEN Reven Pharmaceuticals, Inc.
86623712 08 May 2015 | on 26 Feb 2019
| Pharmaceutical research and development in the fields of cardiovascula... Class 042 Class 042 Computer & Software Services & Scientific Services Pharmaceutical research and development in the fields of cardiovascular disease, vascular therapy, skin conditions, diabetic conditions, cancer, infectious disease, sports enhancement, nerve system disease, brain disease and mitochondrial disease; Pharmaceutical services, namely, the development of pharmaceuticals for the treatment of cardiovascular disease, vascular therapy, skin conditions, diabetic conditions, cancer, infectious disease, sports enhancement, nerve system disease, brain disease and mitochondrial disease | | | REVEN PHARMACEUTICALS Reven Pharmaceuticals, Inc.
86628046 13 May 2015 | on 26 Feb 2019
| Pharmaceutical research and development in the fields of cardiovascula... Class 042 Class 042 Computer & Software Services & Scientific Services Pharmaceutical research and development in the fields of cardiovascular disease, vascular therapy, skin conditions, diabetic conditions, cancer, infectious disease, sports enhancement, nerve system disease, brain disease and mitochondrial disease; Pharmaceutical services, namely, the development of pharmaceuticals for the treatment of cardiovascular disease, vascular therapy, skin conditions, diabetic conditions, cancer, infectious disease, sports enhancement, nerve system disease, brain disease and mitochondrial disease | | 
